Delivery Order SPE2DB22D2005-SPE2DB25FJSH6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,082.53 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $3,521.86 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. This non-set-aside, firm fixed-price contract is scheduled for completion by August 14, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $1,994.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors. This competitive award, with no set-aside designation, is scheduled for completion by July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,827.91 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on August 25, 2025, with completion expected by August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a $5,067.81 delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen injectors on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement extending through December 2026. The product will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injections with a ceiling value of $1,571.57. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to support federal medical procurement needs. The contract is set to complete by August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,176.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen injections on August 11, 2025, with completion targeted for August 12, 2025. This non-competitive, non-set-aside order is being performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,448.81 on July 21, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections. This is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, to be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. As a child contract action, this delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $17,489.37 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injections. This non-set-aside, firm fixed-price delivery order was competitively awarded on August 15, 2025, with an ultimate completion date of August 18, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $4,212.77 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors, with an ultimate completion date of August 11, 2025. This competitive award, issued on a firm fixed price basis, represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026). The pharmaceutical distributor,...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJSH6Delivery Order
The Defense Logistics Agency awarded a $5,723.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-competitive delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to distribute a broad range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills delivery orders for specialty medications, branded and generic drugs, vaccines, and medical devices across multiple therapeutic domains for the Defense Health Agency and other military healthcare systems. The delivery order for Mounjaro, a diabetes medication, reflects the contractor's established capability to supply specialized pharmaceutical products through the DLA Medical Supply Chain. As a non-set-aside award, this order was competitively awarded and demonstrates the contractor's proven performance in meeting federal medical supply requirements on an expedited basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 8/21/25 |